Prospective Randomized Multicenter Study in First-Line Treatment of Advanced progredIeNT Follicular And Other IndoleNt and Mantle Cell Lymphomas.

Trial Profile

Prospective Randomized Multicenter Study in First-Line Treatment of Advanced progredIeNT Follicular And Other IndoleNt and Mantle Cell Lymphomas.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 31 Mar 2017

At a glance

  • Drugs Rituximab (Primary) ; Bendamustine
  • Indications B cell lymphoma; Follicular lymphoma; MALT lymphoma; Mantle-cell lymphoma; Waldenstrom's macroglobulinaemia
  • Focus Therapeutic Use
  • Acronyms MAINTAIN
  • Most Recent Events

    • 30 Apr 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Apr 2020 to 1 Apr 2022.
    • 11 Dec 2012 Results have been presented at the Annual Meeting of the American Society of Hematology (ASH) in December 2012 according to a Mundipharma media release.
    • 10 Dec 2012 Results of induction therapy in patients with Waldenstrom's macroglobulinaemia presented at the 54th Annual Meeting and Exposition of the American Society of Hematology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top